Preplanned secondary analysis of the phase 3 DBCG Proton trial (167 patients with breast cancer or DCIS needing adjuvant RT): proton therapy gave more grade 2–3 dermatitis at week 5 than photon RT (71% vs 20%), all transient. Non-skin side effects were similar.
Secondary analysisn = 167
Høgsbjerg et al. Acute Radiation Side Effects of Proton Versus Photon Therapy Following Surgery for Early Breast Cancer, a Substudy of the Randomized Controlled Danish Breast Cancer Group Proton Trial